跳至主要内容
临床试验/NCT03017703
NCT03017703已完成不适用

The Role of Aldosterone in Diabetes Related Vascular Disease, a New Therapeutic Target?

University of Southern Denmark1 个研究点 分布在 1 个国家目标入组 27 人开始时间: 2016年12月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
27
试验地点
1
主要终点
Insulin sensitivity measured by a insulin clamp

研究概览

简要总结

The importance of Aldosterone for endothelial function and Insulin resistance observed within patients with type 2 diabetes

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
40 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed diabetic < 5 Yrs.
  • BMI < 32 kg/m2
  • Non-smoking
  • Blood pressure < 140/90 mmHg (treatment with maximum of two antihypertensive drugs)

排除标准

  • Insulin treatment
  • Hypertension (>140/90 mmHg)
  • Sequelae to diabetes
  • Known chronic diseases
  • Pregnancy or birth within 3 month
  • Alcohol misuse

研究组 & 干预措施

Type 2 Diabetes

Experimental

8 weeks of treatment with Aldosterone blocker Eplerenone

干预措施: Eplerenone (Drug)

Healthy

Experimental

8 weeks of treatment with Aldosterone blocker Eplerenone

干预措施: Eplerenone (Drug)

结局指标

主要结局

Insulin sensitivity measured by a insulin clamp

时间窗: 8 weeks

Glucose infusion rate during euglycaemic-hyperinsulinaemic clamp

Vascular function

时间窗: 8 weeks

Femoral arterial blood flow in response to femoral arterially infused ACh

次要结局

  • Vascular function(8 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Stefan Mortensen

Associate Professor

University of Southern Denmark

研究点 (1)

Loading locations...

相似试验

The Role of Aldosterone in Circulatory Disorders... | 临床试验